Towarzystwo Ubezpieczeń Wzajemnych MedicumMutual insurance society in liquidation

Other personal and property insurance

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2015-11-16
Share capital
21,005,000.00 PLN
Registered address
ul. Staniewicka 14A, 03-310 Warszawa, Poland
Electronic delivery address
AE:PL-48192-72916-TTHCA-19

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2024, 15 days late). 3 of 6 audited by a statutory auditor.

  • 202510/06/2026
  • 202430/07/2025
  • 202306/06/2024
  • 202212/06/2023
  • 202113/06/2022
  • 202030/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Trademarks

Towarzystwo Ubezpieczeń Wzajemnych Medicum holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2010.

MarkNumberClassesStatusProtected until
TUW MEDICUM(word)Z.36909836Protected Apr 13, 2030
MarkProtected until
TUW MEDICUM(word)Apr 13, 2030

Authorized Representatives

Ryszard Bogusław Frączek – Liquidator

Supervisory board

Adam Stanisław Rozwadowski – Supervisory Board Member
Krzysztof Bernard Wojtas – Supervisory Board Member
Helena Olechowska – Supervisory Board Member
Jerzy Szejwian – Supervisory Board Member
Marian Małecki – Supervisory Board Member

Beneficial owners

No beneficial owners recorded for the entity Towarzystwo Ubezpieczeń Wzajemnych Medicum.

Bank accounts

Was a VAT taxpayer from 2016-06-28 to 2022-09-14.

Reason for removal: Art. 96 ust. 9a pkt 3 (VAT returns showing no transactions filed for 6 consecutive months or 2 quarters)

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

19 notices recorded in the Court and Commercial Gazette (MSiG).

Publication dateEvent
May 11, 2026Shareholders' meeting convened
Jul 7, 2025Shareholders' meeting convened
Jun 9, 2025Shareholders' meeting convened
May 13, 2024Shareholders' meeting convened
May 23, 2023Shareholders' meeting convened

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,995
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$4,147
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$4,113

Change history

DateEvent
2020-09-28Name change
2020-07-30Liquidation opened
2019-06-26Share capital increase
2018-05-11Share capital increase
2017-12-21Share capital increase

FAQ

Last updated: 2026-08-06